Abstract
Background: Histiocytic sarcoma affecting the central nervous system (CNS HS) in dogs may present as primary or disseminated disease, often characterized by inflammation. Prognosis is poor, and imaging differentiation from other CNS tumors can be problematic. Objective: To characterize the clinicopathological inflammatory features, breed predisposition, and survival in dogs with CNS HS. Animals: One hundred two dogs with HS, 62 dogs with meningioma. Methods: Retrospective case series. Records were reviewed for results of cerebrospinal fluid (CSF) analysis, CBC, treatment, and outcome data. Results: Predisposition for CNS HS was seen in Bernese Mountain Dogs, Golden Retrievers, Rottweilers, Corgis, and Shetland Sheepdogs (P ≤.001). Corgis and Shetland Sheepdogs had predominantly primary tumors; Rottweilers had exclusively disseminated tumors. Marked CSF inflammation was characteristic of primary rather than disseminated HS, and neoplastic cells were detected in CSF of 52% of affected dogs. Increased neutrophil to lymphocyte ratios were seen in all groups relative to controls (P
Author supplied keywords
Cite
CITATION STYLE
Toyoda, I., Vernau, W., Sturges, B. K., Vernau, K. M., Rossmeisl, J., Zimmerman, K., … Dickinson, P. J. (2020). Clinicopathological characteristics of histiocytic sarcoma affecting the central nervous system in dogs. Journal of Veterinary Internal Medicine, 34(2), 828–837. https://doi.org/10.1111/jvim.15673
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.